Which molecule class segment is expected to contribute significant share in the obesity GLP-1 market in 2025
Starting July 1, 2026, Medicare will offer more affordable access to certain weight loss medications through a temporary pilot program called the Medicare GLP-1 Bridge , which runs through December 31, 2027
Yeghiazarians Y, Jneid H, Tietjens JR, Redline S, Brown DL, El-Sherif N, Mehra R, Bozkurt B, Ndumele CE, Somers VK
Our guides on retatrutide vs semaglutide and the retatrutide dose guide explore what this next-generation medication may offer
The newer cyclic peptide work coming out of the Suga lab is exploring intracellular targets that injectable peptides can't reach
The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150+ genetic insights including variants in FTO, GLP1R, and MC4R that may shape baseline GLP-1, appetite-regulation, and energy-balance biology